191 related articles for article (PubMed ID: 37905571)
1. MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression.
Sun Y; Jin X; Meng J; Guo F; Chen T; Zhao X; Wu H; Ren D
EMBO J; 2023 Dec; 42(23):e114558. PubMed ID: 37905571
[TBL] [Abstract][Full Text] [Related]
2. Increasing kinase domain proximity promotes MST2 autophosphorylation during Hippo signaling.
Tran T; Mitra J; Ha T; Kavran JM
J Biol Chem; 2020 Nov; 295(47):16166-16179. PubMed ID: 32994222
[TBL] [Abstract][Full Text] [Related]
3. The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in phagocytes.
St Louis BM; Quagliato SM; Su Y-T; Dyson G; Lee P-C
mBio; 2024 May; 15(5):e0342923. PubMed ID: 38624208
[TBL] [Abstract][Full Text] [Related]
4. MAP4K2 connects the Hippo pathway to autophagy in response to energy stress.
Seo G; Mckinley J; Wang W
Autophagy; 2024 Mar; 20(3):704-706. PubMed ID: 37937799
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
6. TRIMming away colon cancer: TRIM21-mediated ubiquitination as an activator of the Hippo tumor suppressor pathway.
Benton D; Chernoff J
Cell Chem Biol; 2023 Jul; 30(7):699-701. PubMed ID: 37478825
[TBL] [Abstract][Full Text] [Related]
7. Salvador has an extended SARAH domain that mediates binding to Hippo kinase.
Cairns L; Tran T; Fowl BH; Patterson A; Kim YJ; Bothner B; Kavran JM
J Biol Chem; 2018 Apr; 293(15):5532-5543. PubMed ID: 29519817
[TBL] [Abstract][Full Text] [Related]
8. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
Saha K; Adhikary G; Eckert RL
J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
[TBL] [Abstract][Full Text] [Related]
9. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells.
Ge L; Wang H; Xu X; Zhou Z; He J; Peng W; Du F; Zhang Y; Gong A; Xu M
J Cell Mol Med; 2020 Jan; 24(2):1969-1979. PubMed ID: 31851779
[TBL] [Abstract][Full Text] [Related]
10. Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.
García-Gutiérrez L; Fallahi E; Aboud N; Quinn N; Matallanas D
Cell Death Dis; 2022 Aug; 13(8):692. PubMed ID: 35941108
[TBL] [Abstract][Full Text] [Related]
11. Dimerization and autophosphorylation of the MST family of kinases are controlled by the same set of residues.
Weingartner KA; Tran T; Tripp KW; Kavran JM
Biochem J; 2023 Aug; 480(15):1165-1182. PubMed ID: 37459121
[TBL] [Abstract][Full Text] [Related]
12. Changes in Adipose Tissue Gene Expression of the Core Components of the Hippo Signaling Pathway in Young Adults with Uncomplicated Overweight or Obesity Following Weight Loss.
Nikołajuk A; Stefanowicz M; Strączkowski M; Karczewska-Kupczewska M
J Nutr; 2023 Mar; 153(3):665-672. PubMed ID: 36805181
[TBL] [Abstract][Full Text] [Related]
13. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
14. Histone arginine methylation by Prmt5 is required for lung branching morphogenesis through repression of BMP signaling.
Li Q; Jiao J; Li H; Wan H; Zheng C; Cai J; Bao S
J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29950483
[TBL] [Abstract][Full Text] [Related]
15. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
[TBL] [Abstract][Full Text] [Related]
16. The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma.
Holmes B; Benavides-Serrato A; Saunders JT; Landon KA; Schreck AJ; Nishimura RN; Gera J
J Neurooncol; 2019 Oct; 145(1):11-22. PubMed ID: 31473880
[TBL] [Abstract][Full Text] [Related]
17. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.
Li Y; Chitnis N; Nakagawa H; Kita Y; Natsugoe S; Yang Y; Li Z; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
Cancer Discov; 2015 Mar; 5(3):288-303. PubMed ID: 25582697
[TBL] [Abstract][Full Text] [Related]
18. Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.
Yi M; Ma Y; Chen Y; Liu C; Wang Q; Deng H
Mol Cell Proteomics; 2020 Nov; 19(11):1910-1920. PubMed ID: 32868396
[TBL] [Abstract][Full Text] [Related]
19. Biophysical characterization of SARAH domain-mediated multimerization of Hippo pathway complexes in
Cairns L; Patterson A; Weingartner KA; Koehler TJ; DeAngelis DR; Tripp KW; Bothner B; Kavran JM
J Biol Chem; 2020 May; 295(18):6202-6213. PubMed ID: 32213597
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between Arg methylation and Ser phosphorylation modulates apoptosis signal-regulating kinase 1 activation in endothelial cells.
Chen M; Qu X; Zhang Z; Wu H; Qin X; Li F; Liu Z; Tian L; Miao J; Shu W
Mol Biol Cell; 2016 Apr; 27(8):1358-66. PubMed ID: 26912789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
